Royalty Report: Medical, Device, Delivery – Collection: 26013


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Delivery
  • Diagnostic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 26013

License Grant
The Licensor hereby grants to Licensee, the right and worldwide exclusive License, and the worldwide nonexclusive subLicense the technology.
License Property
The rights Licensed to Licensee hereunder shall extend to its affiliates designated in writing by Licensee.

Licensee shall have the exclusive right under patent rights and the nonexclusive right under License rights to grant subLicenses to third parties other than affiliates in its discretion.

The technology is entitled Speed Control System for Implanted Blood Pumps, US. Patent No. 5,888,242 (filed November 1, 1996), and US. Patent No. 6,066,086 Speed control system for implanted blood pumps (filed March 4, 1998), including the right to subLicense such technology.

Field of Use
Speed control system for implanted blood pumps

IPSCIO Record ID: 27818

License Grant
The Licensor grants the Licensee an exclusive License for the life of the Patent Rights, to practice the methods, and to make, use, sell, offer to sell, and import the Licensed Product, throughout the Licensed Territories and all other territories of the world.
License Property
The Licensee shall have the exclusive right to grant sublicenses to third parties.

Patent Rights means Licensor's rights in and to
the U.S. patent application having serial no. 08/850,598, filed May 2, 1997, entitled Hybrid Magnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method, and any patent issuing thereon;  the U.S. patent application having serial no. 09/064,352, filed April 22, 1998, entitled Implantable Centrifugal Blood Pump with Hybrid Magnetic Bearings, and any patent issuing thereon; the U.S. patent application having serial no. 08/850,156, filed May 2, 1997, entitled Electromagnetically Suspended and Rotated Centrifugal Pumping Apparatus and Method, and any patent issuing thereon.

Field of Use
The Licensee desires to obtain exclusive rights to the Inventions and any patent applications relating to an implantable blood pump, in order to develop and commercialize the Inventions.

IPSCIO Record ID: 1804

License Grant
The Company hereby grants the worldwide right to manufacture, cause to be manufactured, promote, sell, market, distribute and use the Pump Technology; programmable implantable insulin pump system.
License Property
Implantable microinfusion pump systems intended for in vivo use; utilizes Pump Technology for diabetes or non-diabetes applications. Glucose Controllers, Glucose Monitors, Long-Term Glucose Sensors and the abdominal lead that connects the implantable pump to a Long-Term Glucose Sensor are not Licensed Products.  An apparatus or system which utilizes Glucose Sensing Technology to control an insulin infusion device in a human or in an animal.   Any monitor product utilizing Glucose Sensing Technology to provide indications of glucose concentration or changes in glucose concentration in a human or in an animal.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.